M. Tuberculosis is a causative agent of human Tuberculosis (TB). TB is primarily an illness of the respiratory system, and is spread by coughing and sneezing. People suffering from active pulmonary TB are highly infectious. TB has become a global disease with its re-emergence in the western countries in the last decades. Overall, more than 30 % of the world’s population is currently infected with the TB bacillus. TB kills yearly about 2 million people, more than any other infectious disease. Extra pulmonary sites of TB infection commonly include lymph nodes, pleura, and osteoarticular areas, although any organ can be involved. Although, the TB bacterium was identified 100 years ago, the diagnostic methods available suffer from poor sensitivity and specify and are either time consuming or too expensive.

The RAPID 1-2-3® HEMA EXPRESS® TB-XT Test has developed a cost effective in-vitro-diagnostic rapid test kit for the differentiation between M. Tuberculosis and BCG vaccination in Human Whole Blood, Serum or Plasma. This innovative rapid screening test is based on lateral flow immunochromatography and is among the easiest point of care (POC) assay diagnostics in Human Whole Blood, Serum or Plasma.